Skip to main content

Table 1 Laboratory findings on admission (July 2016)

From: Acute hypopituitarism associated with periorbital swelling and cardiac dysfunction in a patient with pituitary tumor apoplexy: a case report

Hematology
 Red blood cells 363 × 104/μL (435–555)
 Hemoglobin 10.5 g/dL (13.7–16.8)
 Hematocrit 32.3% (40.7–50.1)
 White blood cells 4100/μL (3300–8600)
 Platelets 18.7 × 104/μL (15.8–34.8)
Blood chemistry
 Total protein 6.5 g/dL (6.6–8.1)
 Albumin 3.7 g/dL (4.1–5.1)
 Aspartate aminotransferase 19 IU/L (13–33)
 Alanine aminotransferase 15 IU/L (10–42)
 Creatine kinase 57 IU/L (45–163)
 Urea nitrogen 16.3 mg/dL (8.0–18.4)
 Creatinine 1.01 mg/dL (0.65–1.07)
 Sodium 138 mmol/L (138–145)
 Potassium 3.9 mmol/L (3.6–4.8)
 Chloride 103 mmol/L (101–108)
 C-reactive protein 5.53 mg/dL (<0.14)
 Prothrombin time 105.8 seconds (70–130)
 APTT 27.9 seconds (24–32)
 Fibrinogen 278.1 mg/dL (200–400)
 Casual plasma glucose 106 mg/dL (70–139)
 Glycated hemoglobin 4.9% (4.6–6.2)
 Brain natriuretic peptide 421.6 pg/mL (<18.4)
 Plasma osmolality 281 mOsm/L (275–290)
 Plasma arginine vasopressin 2.3 pg/mL  
 Prolactin 28.5 ng/mL (3.6–12.8)
 Thyroid-stimulating hormone 0.03 μIU/mL (0.50–5.00)
 Free triiodothyronine 3.73 pg/mL (2.30–4.00)
 Free thyroxine 0.98 ng/dL (0.90–1.70)
 Adrenocorticotropic hormone 16.3 pg/mL (7.2–63.3)
 Cortisol 1.8 μg/dL (4.5–21.1)
 Dehydroepiandrosterone sulfate 138 ng/mL (50– 2,530)
 Aldosterone 6.2 ng/dL (3.0–15.9)
 Plasma renin activity 0.2 ng/mL/h (0.2–2.3)
 Noradrenaline 0.70 ng/mL (0.10–0.50)
 Adrenaline 0.06 ng/mL (0–0.10)
 Dopamine 0.01 ng/mL (0–0.03)
Urinalysis
 Specific gravity 1.024 (1.005–1.020)
 pH 5.5 (5.5–7.5)
 Glucose Negative  
 Protein Negative  
 Occult blood Negative  
 Inflammatory cells Negative  
  1. The reference range for each parameter is shown in parentheses
  2. Blood samples were taken with the patient in the supine position at 9 AM of the day of admission. The patient underwent thyroid hormone replacement therapy with oral levothyroxine (100 μg/day)
  3. APTT activated partial thromboplastin time